We're sorry but this app doesn't work properly without JavaScript enabled. Please enable it to continue. Epic Investment Partners Views: The Week Ahead - MeDirect Bank Malta

Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Epic Investment Partners Views: The Week Ahead

This week we have earnings from tech giants, European banks and oil majors, rate decisions from the ECB and BoE (Thu), and the US January employment report (Fri).  

We start the week with the final January HCOB manufacturing PMIs across the globe, and the UK and US S&P Global manufacturing PMIs. UK house prices and the US ISM manufacturing will also draw market attention on Groundhog Day, today. On Tuesday, focus turns to US JOLTS job openings print, while the IMF’s MD Georgieva speaks at the World Governments Summit in Dubai. The China RatingDog services PMI, Eurozone CPI and US ADP employment change and ISM services index figures are due on Wednesday. We also have Alphabet and UBS earnings reports on Wednesday, with Amazon and BNP Paribas reporting on Thursday. The ECB and BoE are both expected to hold rates on Thursday, and Germany factory orders, and US initial jobless claims will be of interest. The US employment figures will take centre stage on Friday. Markets currently expect employment to remain at 4.4%, and the non farm payroll is estimated at +65k in January. The University of Michigan Consumer confidence and sentiment figures will also be key for markets following recent signs of fragile household confidence. 

Central bank chatter includes the Fed’s Bostic, and BoE’s Breeden on Monday. The Fed’s Bowman speaks on Tuesday. The ECB’s Lagarde and BoE’s Bailey both hold new conferences after the central banks’ rate decisions on Thursday. The ECBs Kocher and BoE’s Pill attend separate events on Friday.  

Market sentiment last week reflected a high-stakes tug-of-war between “Big Tech” earnings and shifting US monetary and trade policy expectations. Although the S&P 500 briefly crossed the historic 7,000 level on Wednesday, momentum faded as investors digested mixed signals from the Magnificent Seven and a broader “wall of worry” extending beyond corporate fundamentals. Sentiment was further tested by escalating US trade rhetoric, including new 25% tariff threats on South Korea and potential 100% duties on Canada, as well as the market-moving nomination of Kevin Warsh to succeed Jerome Powell as Fed Chair when his term ends in May. 

The FOMC held rates steady at 3.50%–3.75% in a 10–2 vote, signalling a pause in the easing cycle amid signs of a stabilising labour market. Chair Powell struck a tone of “cautious patience”, upgrading his assessment of growth to “solid” while stressing that policy is not on a preset path and will remain data-dependent. While acknowledging inflation remains near 3%, partly due to tariff related goods pricing, Powell firmly defended the Fed’s institutional independence, noting it has “served the public well” as his term approaches its conclusion. 

Market moves were relatively contained. The 10-year US Treasury yield ended the week little changed at 4.24%, while the S&P 500 gained 0.34%. The US dollar weakened further, with the DXY falling 0.62%, pressured by policy uncertainty and speculation around coordinated FX intervention to support the yen. A partial rebound on Friday followed the Warsh nomination, though broader flows continued to favour gold and non-US currencies. Brent crude briefly touched a four-month high above $70pb, driven by Iran-related geopolitical risk and weather-related supply disruptions, before retreating after OPEC+ reaffirmed plans to keep output steady through March and signals of diplomatic de-escalation between Washington and Tehran emerged. 

China’s policy stance continues to evolve, with authorities leaning into digital services and investment in physical assets to absorb labour, even as headline manufacturing remains soft, with the official PMI at 49.3. In contrast, the private sector is showing early signs of recovery, with the RatingDog (Caixin) PMI rising to 50.3, indicating improving export demand and labour market stabilisation. This private-sector resilience, alongside strong household demand for gold as a savings vehicle, points to an economy adapting through innovation while navigating its structural transition toward more sustainable growth.   


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.